Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the United States. Around 80-90% of thyroid cancer cases are papillary cancer. Papillary ...

Today, we’re going to be focusing on differentiated thyroid cancer, but even with the diagnosis of differentiated thyroid cancer, there are multiple subtypes. Maybe I could ask Bryan to go into a ...

(2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on ...

More than one-third of patients treated for differentiated thyroid cancer reported elevated anxiety and more than 15% reported a high level of depression at an annual follow-up, according to study ...

One nice thing about differentiated thyroid cancer is that it usually produces a protein called thyroglobulin. Thyroglobulin in the blood stream indicates the presence of thyroid tissue. If I have a ...

Medullary thyroid cancer is less differentiated and forms in C cells, which produce calcitonin. Calcitonin is a hormone that helps regulate calcium levels in the blood.

Differentiated thyroid cancer (which is further broken down into subtypes of papillary, follicular, or Hurthle cell carcinoma) accounts for well over 90 percent of thyroid cancers.

Complete remission of differentiated thyroid cancer was more likely in patients treated with metformin than in the other 2 groups. Multivariate analysis results showed that extrathyroidal ...

Because well-differentiated thyroid cancer cells still behave to some extent like normal thyroid cells, they will take up iodine, a critical element for making thyroid hormone.

Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to ...

Well-differentiated tumors (papillary and follicular thyroid cancer) are highly treatable and usually curable, notes the National Library of Medicine's PDQ summary.

Poorly differentiated thyroid cancer is uncommon, accounting for fewer than 5% of thyroid cancers. Poorly differentiated thyroid cancer is more clinically aggressive and can be challenging to treat.